Mettler-Toledo International, Inc. $MTD Shares Bought by Bank of Montreal Can

Bank of Montreal Can increased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 5.4% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 25,937 shares of the medical instruments supplier’s stock after buying an additional 1,337 shares during the period. Bank of Montreal Can’s holdings in Mettler-Toledo International were worth $30,469,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. WPG Advisers LLC bought a new position in Mettler-Toledo International in the first quarter worth about $41,000. Zions Bancorporation National Association UT acquired a new stake in shares of Mettler-Toledo International during the 1st quarter worth approximately $43,000. Sound Income Strategies LLC lifted its holdings in shares of Mettler-Toledo International by 477.8% in the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after purchasing an additional 43 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in Mettler-Toledo International during the 2nd quarter valued at approximately $63,000. Finally, Geneos Wealth Management Inc. grew its stake in Mettler-Toledo International by 83.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Up 0.2%

Shares of Mettler-Toledo International stock opened at $1,442.42 on Friday. The business has a fifty day simple moving average of $1,317.78 and a 200-day simple moving average of $1,231.98. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,454.68. The firm has a market cap of $29.71 billion, a price-to-earnings ratio of 36.53, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. During the same period in the previous year, the company earned $10.21 earnings per share. Mettler-Toledo International’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the transaction, the director owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 1,527 shares of company stock valued at $1,994,981 over the last ninety days. Insiders own 0.77% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have issued reports on MTD shares. Citigroup raised their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Bank of America boosted their target price on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Evercore ISI upped their target price on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Finally, Barclays lifted their price target on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Five research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, Mettler-Toledo International has an average rating of “Hold” and an average price target of $1,336.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.